MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Celldex Therapeutics Company Profile (NASDAQ:CLDX)

Consensus Ratings for Celldex Therapeutics (NASDAQ:CLDX) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $38.71 (66.16% upside)

Analysts' Ratings History for Celldex Therapeutics (NASDAQ:CLDX)
Show:
DateFirmActionRatingPrice TargetActions
6/30/2015OppenheimerReiterated RatingBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015Roth CapitalReiterated RatingBuy$43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Brean CapitalReiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Cantor FitzgeraldReiterated RatingBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015WBB SecuritiesReiterated RatingBuy$30.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Cowen and CompanySet Price TargetBuy$33.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Cantor FitzgeraldReiterated RatingBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2015Jefferies GroupReiterated RatingBuy$24.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015Cantor FitzgeraldBoost Price TargetBuy$33.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Cowen and CompanySet Price TargetBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Cantor FitzgeraldSet Price TargetBuy$33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014OppenheimerReiterated Rating$36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014Roth CapitalBoost Price TargetBuy$40.00 -> $43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/26/2014Cowen and CompanyInitiated CoverageOutperform$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014Jefferies GroupBoost Price TargetBuy$29.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014Cantor FitzgeraldReiterated RatingBuy$39.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2014OppenheimerLower Price TargetOutperform$40.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2013Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013OppenheimerReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013Cantor FitzgeraldReiterated RatingBuy$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013Roth CapitalBoost Price TargetBuy$34.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/7/2013Ned Davis ResearchInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2013Cantor FitzgeraldReiterated RatingBuy$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2013OppenheimerBoost Price Target$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013GuggenheimBoost Price TargetBuy$26.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013Cantor FitzgeraldBoost Price TargetBuy$39.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013Leerink SwannBoost Price TargetOutperform$28.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013WedbushReiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/17/2013Jefferies GroupBoost Price TargetBuy$25.00 -> $29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2013WedbushReiterated RatingOutperform$20.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013OppenheimerBoost Price Target$16.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Leerink SwannBoost Price Target$18.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2013Jefferies GroupBoost Price Target$19.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/5/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha